Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy

Oncologist

Volumn 13, Issue 12, 2008, Pages 1285-1295

  Dietrich, Jörg ^a   Monje, Michelle ^b   Wefel, Jeffrey ^c   Meyers, Christina ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemotherapy; Cognitive dysfunction; Neural stem cells; Neurotoxicity; Progenitor cells; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CARMOFUR; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; MISONIDAZOLE; NALTREXONE; THIOTEPA;

ASEPTIC MENINGITIS; ATTENTION; BRAIN ATROPHY; BRAIN DISEASE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CEREBELLAR TO; COGNITIVE DEFECT; CORRELATION ANALYSIS; CRANIAL NEUROPATHY; DEMENTIA; DRUG MEGADOSE; HEADACHE; HIPPOCAMPUS; HUMAN; INFORMATION PROCESSING; LEARNING DISORDER; LEUKOENCEPHALOPATHY; MEMORY; NEOPLASM; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION NECROSIS; REVIEW; SEIZURE; SPINAL CORD DISEASE; STEM CELL; VASCULAR DISEASE; VISUAL IMPAIRMENT; WHITE MATTER;

ANTINEOPLASTIC AGENTS; COGNITION DISORDERS; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; NEURONS; RADIOTHERAPY; STEM CELLS;

EID: 58749089099     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2008-0130     Document Type: Review

References (106)

1. Butler RW, Haser JK. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev 2006;12:184-191.
2. Alvarez JA, Scully RE, Miller TL et al. Long-term effects of treatments for childhood cancers. Curr Opin Pediatr 2007;19:23-31.
3. Wefel JS, Lenzi R, Theriault RL et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-2299.
4. Schagen SB, Muller MJ, Boogerd W et al. Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 2006;98:1742-1745.
5. Hurria A, Rosen C, Hudis C et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study. J Am Geriatr Soc 2006;54:925-931.
6. Mahaley MS Jr, Whaley RA, Blue M et al. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas. J Neurooncol 1986;3:297-314.
7. Hook CC, Kimmel DW, Kvols LK et al. Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 1992; 31:262-267.
8. Lai R, Abrey LE, Rosenblum MK et al. Treatment-induced leukoencephalopathy in primary CNS lymphoma: A clinical and autopsy study. Neurology 2004;62:451- 456.
9. Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: An update and review of the literature. Acta Neuropathol 2006;111:197-212.
10. Dietrich J, Kempermann G. Role of endogenous neural stem cells in neurological disease and brain repair. Adv Exp Med Biol 2006;557:191-220.
11. McTigue DM, Tripathi RB. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem 2008;107:1-19.
12. Kempermann G. The neurogenic reserve hypothesis: What is adult hippocampal neurogenesis good for? Trends Neurosci 2008;31:163-169.
13. Monje ML, Mizumatsu S, Fike JR et al. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002;8:955-962.
14. Dietrich J, Han R, Yang Y et al. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 2006;5:22.
15. Han R, Yang YM, Dietrich J et al. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 2008;7:12.
16. Keime-Guibert F, Napolitano M, Delattre JY. Neurological complications of radiotherapy and chemotherapy. J Neurol 1998;245:695-708.
17. Dropcho EJ. Neurotoxicity of cancer chemotherapy. Semin Neurol 2004; 24:419-426.
18. Minisini A, Atalay G, Bottomley A et al. What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol 2004;5:273-282.
19. Wefel JS, Kayl AE, Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: A conceptual review of an emerging target. Br J Cancer 2004;90:1691-1696.
20. Dietrich J, Wen P. Neurologic complications of chemotherapy. In: Schiff D, Kesari S, Wen P, eds. Cancer Neurology in Clinical Practice, Second Edition. Totowa, NJ: Humana Press Inc., 2008:287-326.
21. Schagen SB, van Dam FS, Muller MJ et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999;85: 640-650.
22. Brezden CB, Phillips KA, Abdolell M et al. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000;18: 2695-2701.
23. Omuro AM, Ben-Porat LS, Panageas KS et al. Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol 2005;62:1595-1600.
24. Duffner PK. The long term effects of chemotherapy on the central nervous system. J Biol 2006;5:21.
25. Heflin LH, Meyerowitz BE, Hall P et al. Cancer as a risk factor for long-term cognitive deficits and dementia. J Natl Cancer Inst 2005;97:854-856.
26. Roe CM, Behrens MI, Xiong C et al. Alzheimer disease and cancer. Neurology 2005;64:895- 898.
27. Wefel JS, Meyers CA. Cancer as a risk factor for dementia: A house built on shifting sand. J Natl Cancer Inst 2005;97:788-789.
28. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000;15:603- 630.
29. Shilling V, Jenkins V, Morris R et al. The effects of adjuvant chemotherapy on cognition in women with breast cancer - preliminary results of an observational longitudinal study. Breast 2005;14:142-150.
30. Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of noncentral nervous system cancer and cancer therapy. Neuropsychol Rev 2008;18:121-131.
31. McAllister TW, Ahles TA, Saykin AJ et al. Cognitive effects of cytotoxic cancer chemotherapy: Predisposing risk factors and potential treatments. Curr Psychiatry Rep 2004;6:364-371.
32. Okcu MF, Selvan M, Wang LE et al. Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res 2004; 10:2618-2625.
33. Largillier R, Etienne-Grimaldi MC, Formento JL et al. Pharmacogenetics of capecitabine in advanced breast cancer patients. Clin Cancer Res 2006; 12:5496-5502.
34. Krajinovic M, Robaey P, Chiasson S et al. Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL. Pharmacogenomics 2005;6:293-302.
35. Chen Y, Lomnitski L, Michaelson DM et al. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 1997;80:1255-1262.
36. Ahles TA, Saykin AJ, Noll WW et al. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 2003;12:612-619.
37. Egan MF, Kojima M, Callicott JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-269.
38. Egan MF, Goldberg TE, Kolachana BS et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001;98:6917- 6922.
39. Saykin AJ, Ahles TA, McDonald BC. Mechanisms of chemotherapy-induced cognitive disorders: Neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 2003;8:201-216.
40. Stemmer SM, Stears JC, Burton BS et al. White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support. AJNR Am J Neuroradiol 1994;15:1267-1273.
41. Shapiro WR, Chernik NL, Posner JB. Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neurol 1973;28: 96-102.
42. Bashir R, Hochberg FH, Linggood RM et al. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme. J Neurosurg 1988;68:917-919.
43. Rosenblum MK, Delattre JY, Walker RW et al. Fatal necrotizing encephalopathy complicating treatment of malignant gliomas with intra-arterial BCNU and irradiation: A pathological study. J Neurooncol 1989;7:269-281.
44. Newton HB. Intra-arterial chemotherapy of primary brain tumors. Curr Treat Options Oncol 2005;6:519-530.
45. Brown MS, Stemmer SM, Simon JH et al. White matter disease induced by high-dose chemotherapy: Longitudinal study with MR imaging and proton spectroscopy. AJNR Am J Neuroradiol 1998;19:217-221.
46. Silverman DH, Dy CJ, Castellon SA et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 2007;103:303-311.
47. Inagaki M, Yoshikawa E, Matsuoka Y et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 2007;109:146-156.
48. Madhyastha S, Somayaji SN, Rao MS et al. Hippocampal brain amines in methotrexate-induced learning and memory deficit. Can J Physiol Pharmacol 2002;80:1076-1084.
49. Schneiderman B. Hippocampal volumes smaller in chemotherapy patients. Lancet Oncol 2004;5:202.
50. Baehring JM, Fulbright RK. Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. J Neurol Neurosurg Psychiatry 2008;79:535-539.
51. Crossen JR, Garwood D, Glatstein E et al. Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627-642.
52. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789-796.
53. Duffner PK. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist 2004;10:293-310.
54. Roman DD, Sperduto PW. Neuropsychological effects of cranial radiation: Current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995;31:983-998.
55. Anderson VA, Godber T, Smibert E et al. Cognitive and academic outcome following cranial irradiation and chemotherapy in children: A longitudinal study. Br J Cancer 2000;82:255-262.
56. Moore BD 3rd, Copeland DR, Ried H et al. Neurophysiological basis of cognitive deficits in long-term survivors of childhood cancer. Arch Neurol 1992;49:809-817.
57. Abayomi OK. Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol 1996;35:659-663.
58. Surma-aho O, Niemela M, Vilkki J et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 2001; 56:1285-1290.
59. Lee AW, Kwong DL, Leung SF et al. Factors affecting risk of symptomatic temporal lobe necrosis: Significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 2002;53:75- 85.
60. Sheline GE. Radiation therapy of brain tumors. Cancer 1977;39:873-881.
61. Wong CS, Van der Kogel AJ. Mechanisms of radiation injury to the central nervous system: Implications for neuroprotection. Mol Interv 2004;4: 273-284.
62. Meyers CA, Geara F, Wong PF et al. Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys 2000;46: 51-55.
63. Gregor A, Cull A, Traynor E et al. Neuropsychometric evaluation of long-term survivors of adult brain tumours: Relationship with tumour and treatment parameters. Radiother Oncol 1996;41:55-59.
64. Strother DR. Tumors of the central nervous system. In: Pizzo PPA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott, Williams and Wilkins, 2002:751-824.
65. Abayomi OK. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol 2002;41:346-351.
66. Merchant TE, Kiehna EN, Li C et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys 2006;65:210-221.
67. Merchant TE, Kiehna EN, Kun LE et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg 2006;104:94-102.
68. Correa DD, DeAngelis LM, Shi W et al. Cognitive functions in low-grade gliomas: Disease and treatment effects. J Neurooncol 2007;81:175-184.
69. Torres IJ, Mundt AJ, Sweeney PJ et al. A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology 2003;60:1113-1118.
70. Vigliani MC, Sichez N, Poisson M et al. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int J Radiat Oncol Biol Phys 1996;35:527-533.
71. Oppenheimer JH, Levy ML, Sinha U et al. Radionecrosis secondary to interstitial brachytherapy: Correlation of magnetic resonance imaging and histopathology. Neurosurgery 1992;31:336-343.
72. Morris JG, Grattan-Smith P, Panegyres PK et al. Delayed cerebral radiation necrosis. Q J Med 1994;87:119-129.
73. Chong VE, Fan YF. Radiation-induced temporal lobe necrosis. AJNR Am J Neuroradiol 1997;18:784-785.
74. Fouladi M, Chintagumpala M, Laningham FH et al. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 2004;22:4551-4560.
75. Thiessen B, DeAngelis LM. Hydrocephalus in radiation leukoencephalopathy: Results of ventriculoperitoneal shunting. Arch Neurol 1998;55: 705-710.
76. Dropcho EJ. Central nervous system injury by therapeutic irradiation. Neurol Clin 1991;9:969-988.
77. Rubin P, Gash DM, Hansen JT et al. Disruption of the blood-brain barrier as the primary effect of CNS irradiation. Radiother Oncol 1994;31:51-60.
78. Béhin A, Delattre JY. Complications of radiation therapy on the brain and spinal cord. Semin Neurol 2004;24:405-417.
79. Belka C, Budach W, Kortmann RD et al. Radiation induced CNS toxicity-molecular and cellular mechanisms. Br J Cancer 2001;85:1233-1239.
80. Noble M, Dietrich J. Intersections between neurobiology and oncology: Tumor origin, treatment and repair of treatment-associated damage. Trends Neurosci 2002;25:103-107.
81. Monje ML, Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol 2003;16:129-134.
82. Fike JR, Rola R, Limoli CL. Radiation response of neural precursor cells. Neurosurg Clin N Am 2007;18:115-127.
83. Zola-Morgan S, Squire LR. Neuroanatomy of memory. Annu Rev Neurosci 1993;16:547-563.
84. Eriksson PS, Perfilieva E, Björk-Eriksson T et al. Neurogenesis in the adult human hippocampus. Nat Med 1998;4:1313-1317.
85. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell 2008;132:645-660.
86. Tada E, Parent JM, Lowenstein DH et al. X-irradiation causes a prolonged reduction in cell proliferation in the dentate gyrus of adult rats. Neuroscience 2000;99:33-41.
87. Peissner W, Kocher M, Treuer H et al. Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus. Brain Res Mol Brain Res 1999;71:61-68.
88. Yazlovitskaya EM, Edwards E, Thotala D et al. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res 2006;66:11179-11186.
89. Parent JM, Tada E, Fike JR et al. Inhibition of dentate granule cell neurogenesis with brain irradiation does not prevent seizure-induced mossy fiber synaptic reorganization in the rat. J Neurosci 1999;19:4508-4519.
90. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003;302:1760-1765.
91. Mizumatsu S, Monje ML, Morhardt DR et al. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res 2003;63:4021-4027.
92. Ekdahl CT, Claasen JH, Bonde S et al. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A 2003;100:13632-13637.
93. Monje ML, Vogel H, Masek M et al. Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Ann Neurol 2007;62:515-520.
94. Morris GM, Hopewell JW, Morris AD. A comparison of the effects of methotrexate and misonidazole on the germinal cells of the subependymal plate of the rat. Br J Radiol 1995;68:406-412.
95. Rzeski W, Pruskil S, Macke A et al. Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol 2004;56:351-360.
96. Mignone RG, Weber ET. Potent inhibition of cell proliferation in the hippocampal dentate gyrus of mice by the chemotherapeutic drug thioTEPA. Brain Res 2006;1111:26-29.
97. Seigers R, Schagen SB, Beerling W et al. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res 2008;186:168-175.
98. Winocur G, Vardy J, Binns MA et al. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 2006;85:66-75.
99. Lipp HP. Neurotoxicity induced by cytostatics. In: Lipp HP, ed. Anticancer Drug Toxicity: Prevention, Management, and Clinical Pharmacokinetics. New York: Marcel Dekker, Inc., 1999:431-453.
100. Valentine AD, Meyers CA, Talpaz M. Treatment of neurotoxic side effects of interferon-alpha with naltrexone. Cancer Invest 1995;13:561-566.
101. Musselman DL, Lawson DH, Gumnick JF et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001;344:961-966.
102. Meyers CA, Weitzner MA, Valentine AD et al. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16:2522-2527.
103. Chan AS, Cheung MC, Law SC et al. Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer 2004;100:398-404.
104. Barton D, Loprinzi C. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: The art of the possible. Clin Breast Cancer 2002;3(suppl 3):S121-S127.
105. Shaw EG, Rosdhal R, D'Agostino RB Jr et al. Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. J Clin Oncol 2006;24:1415-1420.
106. Evans JJ, Wilson BA, Needham P et al. Who makes good use of memory aids? Results of a survey of people with acquired brain injury. J Int Neuropsychol Soc 2003;9:925-935.